NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jason D Graci
PTC Therapeutics - - / United States
Others
AD Scientific Index ID: 4523232
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jason D Graci's MOST POPULAR ARTICLES
1-)
Mechanisms of action of ribavirin against distinct virusesJD Graci, CE CameronReviews in medical virology 16 (1), 37-48, 20065622006
2-)
Quasispecies, error catastrophe, and the antiviral activity of ribavirinJD Graci, CE CameronVirology 298 (2), 175-180, 20021582002
3-)
RNA virus population diversity, an optimum for maximal fitness and virulenceVK Korboukh, CA Lee, A Acevedo, M Vignuzzi, Y Xiao, JJ Arnold, ...Journal of Biological Chemistry 289 (43), 29531-29544, 20141052014
4-)
Therapeutically targeting RNA viruses via lethal mutagenesisJD Graci, CE CameronFuture virology 3 (6), 553-566, 2008912008
5-)
Targeting of hematologic malignancies with PTC299, a novel potent inhibitor of dihydroorotate dehydrogenase with favorable pharmaceutical propertiesL Cao, M Weetall, C Trotta, K Cintron, J Ma, MJ Kim, B Furia, C Romfo, ...Molecular cancer therapeutics 18 (1), 3-16, 2019802019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept